Search Bar & Filters
Found 3 Actively Recruiting clinical trials
Actively Recruiting
Researchers are collecting data through a registry to study the outcomes of implantable cardioverter-defibrillators ICDs placed in ambulatory surgical centers for patients with arrhythmia. The main goals are to determine how often serious complications or adverse events occur with both initial and replacement ICD implants and to evaluate the time and cost efficiency for doctors and patients. This registry gathers information at several points during screening, at the time of implant, and two weeks afterward during a wound check. The study focuses on patients receiving ICD devices in outpatient ambulatory surgical centers, without comparison groups or experimental treatments. Participants will have their implantation success assessed at a two-week follow-up. Data collection includes monitoring for complications and efficiency outcomes. The registry runs from August 2017 until August 2028, and participants will undergo routine clinical evaluations associated with their ICD implantation and follow-up care.
Actively Recruiting
This research aims to compare two different approaches to post-hospitalization follow-up care for children hospitalized with common infections such as pneumonia, skin and soft tissue infections, acute gastroenteritis, or urinary tract infections. The study evaluates whether automatic follow-up visits scheduled at discharge or a more flexible as-needed PRN follow-up approach, where parents monitor symptoms and decide on visits, impact hospital readmission rates and other health outcomes. Participants are randomly assigned to one of two groups. One group receives a recommendation for automatic follow-up, instructing them to schedule and attend a follow-up visit regardless of symptom improvement. The other group receives a recommendation for PRN follow-up, where scheduling a visit at discharge is not required, and parents decide if a visit is necessary based on their childs symptoms. Both groups are monitored to compare outcomes over time. During the study, researchers will track hospital readmissions within 14 days of discharge as the primary outcome. Secondary outcomes include medical interventions and the childs health-related quality of life measured seven days after discharge. Additional factors like healthcare use, parent anxiety, satisfaction, and costs will also be assessed. The study includes follow-up through communications with healthcare providers and monitoring of immunizations and well-child visits. Participation lasts at least through the 14-day post-discharge period to capture these outcomes.
Actively Recruiting
This research evaluates strategies to improve follow-up care after hospital stays for children with bronchiolitis, an acute lung condition. It focuses on comparing two different multi-component approaches intended to increase as-needed PRN follow-up prescriptions by hospital doctors and reduce unnecessary routine follow-up visits by families. The study is led by Seattle Childrens Hospital and addresses a common practice that may often result in unnecessary visits. Participants are divided into three groups those experiencing a moderate-resource implementation strategy, a high-resource implementation strategy, or no intervention as concurrent controls. The moderate-resource strategy involves educational outreach with family materials, audit and feedback on clinician performance, and clinical decision support tools. The high-resource strategy adds small-group facilitation and expert coach-led support on top of the moderate components. Concurrent control hospitals do not receive any intervention but still collect data. During the study, researchers will track adoption of PRN follow-up prescribing within 7 days after hospital discharge and monitor sustainment of these practices. Families and clinicians will be involved in decision-making supported by educational materials. The study will observe how these strategies affect follow-up visit attendance and clinical practice over time, aiming to optimize care for children hospitalized with bronchiolitis. The study runs from November 2025 to December 2029 for children aged up to 24 months.